Utility of Ultra-Low-Pass Whole Genome Sequencing in Bile CfDNA for the Management of Patients With Biliary Strictures

• M. Arechederra,
• C. Rojo,
• M. Rullán,
• M. Elizalde,
• J. Herranz,
• D. Oyón,
• J. Argemí,
• J. Urman,
• M. Ávila,
• C. Berasain

Affiliations

M. Arechederra

Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; CIBERehd, Carlos III Health Institute, Madrid, Spain

C. Rojo

Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain

M. Rullán

IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Department of Gastroenterology and Hepatology, Navarra University Hospital Complex, Pamplona, Spain

M. Elizalde

Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain

J. Herranz

Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain; CIBERehd, Carlos III Health Institute, Madrid, Spain

D. Oyón

University Hospital of Galdakao, Galdakao, Spain

J. Argemí

Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; CIBERehd, Carlos III Health Institute, Madrid, Spain; Internal Medicine Department, Clinica Universidad de Navarra, Pamplona, Spain

J. Urman

IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Department of Gastroenterology and Hepatology, Navarra University Hospital Complex, Pamplona, Spain

M. Ávila

Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; CIBERehd, Carlos III Health Institute, Madrid, Spain

C. Berasain

Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain; CIBERehd, Carlos III Health Institute, Madrid, Spain